All In Biotech

Drug Trial Radar · NCT04821622

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

TALAPRO-3: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, STUDY OF TALAZOPARIB WITH ENZALUTAMIDE VERSUS PLACEBO WITH ENZALUTAMIDE IN MEN WITH DDR GENE MUTATED METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 599 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

599

Actual

Start

May 12, 2021

Primary completion

Feb 18, 2026

Study completion Aug 28, 2027

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
Collaborators
Astellas Pharma Inc
First posted
Mar 29, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination with enzalutamide in participants with DDR-deficient mCSPC.

Conditions

  • Prostate Cancer

Interventions

  • talazoparib plus enzalutamideDrug

    experimental arm

  • Placebo plus enzalutamideDrug

    Active comparator arm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. radiological Progression-Free SurvivalTime frame: randomization up to 3 years

Locations

312 sites in 27 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Arizona Institute of Urology, PLLC

    Tucson, Arizona

  • Beverly Hills Cancer Center

    Beverly Hills, California

  • Adventist Health Glendale

    Glendale, California

  • VA Long Beach Healthcare System

    Long Beach, California

  • Yale-New Haven Hospital

    New Haven, Connecticut

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia

  • Washington Cancer Institute at MedStar Washington Hospital Center

    Washington D.C., District of Columbia

  • AdventHealth Medical Group Hematology and Oncology

    Orlando, Florida

  • Investigational Drug Services, Advent Health Orlando

    Orlando, Florida

  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital

    Austell, Georgia

  • Wellstar Cobb Hospital

    Austell, Georgia

  • Northwest Georgia Oncology Centers, a Service of Tanner Medical Center Villa Rica

    Carrollton, Georgia

  • West Georgia Infusion Center, a Service of Tanner Medical Center Villa Rica

    Carrollton, Georgia

  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital

    Cartersville, Georgia

  • Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital

    Douglasville, Georgia

  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital

    Marietta, Georgia

  • Comprehensive Urologic Care, SC

    Lake Barrington, Illinois

  • Mid-Illinois Hematology & Oncology Associates, Ltd

    Normal, Illinois

  • Henry Ford Health System

    Detroit, Michigan

  • Henry Ford Medical Center - New Center One

    Detroit, Michigan

  • Revive Research Institute, Inc.

    Farmington Hills, Michigan

  • David C. Pratt Cancer Center

    St Louis, Missouri

  • New Jersey Cancer Care, P.A.

    Belleville, New Jersey

  • Premier Medical Group of the Hudson Valley PC

    Poughkeepsie, New York

  • Providence Cancer Institute Franz Clinic

    Portland, Oregon

  • Providence Portland Medical Center

    Portland, Oregon

  • Keystone Urology Specialists

    Lancaster, Pennsylvania

  • Carolina Urologic Research Center, LLC

    Myrtle Beach, South Carolina

  • Bristol Regional Medical Center

    Bristol, Tennessee

  • Ballad Health Cancer Care - Kingsport

    Kingsport, Tennessee

  • Holston Valley Hospital and Medical Center

    Kingsport, Tennessee

  • Indian Path Community Hospital

    Kingsport, Tennessee

  • Kelsey Research Foundation

    Houston, Texas

  • Oncology Consultants, P.A.

    Houston, Texas

  • Kelsey-Seybold Clinic

    Houston, Texas

  • oncology Consultants, P.A.

    Houston, Texas

  • Kelsey-Seybold Clinic

    Houston, Texas

  • Houston Metro Urology

    Houston, Texas

Showing 40 of 312 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.